Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report P Horby, WS Lim, J Emberson, M Mafham, J Bell, L Linsell, N Staplin, ... MedRxiv, 2020.06. 22.20137273, 2020 | 11589* | 2020 |
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study WS Lim, MM Van der Eerden, R Laing, WG Boersma, N Karalus, GI Town, ... Thorax 58 (5), 377-382, 2003 | 3838 | 2003 |
BTS guidelines for the management of community acquired pneumonia in adults: update 2009 WS Lim, SV Baudouin, RC George, AT Hill, C Jamieson, I Le Jeune, ... Thorax 64 (Suppl 3), iii1-iii55, 2009 | 1911 | 2009 |
Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, ... Jama 324 (13), 1330-1341, 2020 | 1847 | 2020 |
Co-infections in people with COVID-19: a systematic review and meta-analysis L Lansbury, B Lim, V Baskaran, WS Lim Journal of infection 81 (2), 266-275, 2020 | 1700 | 2020 |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1638* | 2021 |
Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1460 | 2020 |
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and … J Mair-Jenkins, M Saavedra-Campos, JK Baillie, P Cleary, FM Khaw, ... The Journal of infectious diseases 211 (1), 80-90, 2015 | 1208 | 2015 |
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 905 | 2022 |
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ... The Lancet 396 (10259), 1345-1352, 2020 | 793 | 2020 |
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines WS Lim, JT Macfarlane, TCJ Boswell, TG Harrison, D Rose, M Leinonen, ... Thorax 56 (4), 296-301, 2001 | 765 | 2001 |
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 721 | 2021 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 618* | 2021 |
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009) JS Nguyen-Van-Tam, PJM Openshaw, A Hashim, EM Gadd, WS Lim, ... Thorax 65 (7), 645-651, 2010 | 325 | 2010 |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... Medrxiv, 2021 | 298 | 2021 |
Severity prediction rules in community acquired pneumonia: a validation study WS Lim, S Lewis, JT Macfarlane Thorax 55 (3), 219-223, 2000 | 296 | 2000 |
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol L Sigfrid, TM Drake, E Pauley, EC Jesudason, P Olliaro, WS Lim, ... The Lancet Regional Health–Europe 8, 2021 | 292 | 2021 |
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 285 | 2021 |
Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations S Ahmedzai, IM Balfour-Lynn, T Bewick, R Buchdahl, RK Coker, ... Thorax 66 (Suppl 1), i1-i30, 2011 | 272 | 2011 |